Navigation Links
Self-Retaining Bicanaliculus Intubation Set

ProductsSelf-Retaining Bicanaliculus Intubation Set
Company FCI Ophthalmics Inc.
Item Self-Retaining Bicanaliculus Intubation Set
Features 
Description Nicknamed the SRS, this new and innovative stent allows the physician to intubate the canaliculi in the office right at the chair with just topical anesthetic drops.

The SRS is made of medical grade silicone and is available in three lengths 25mm, 30mm and 35mm (disposable sizers sold separately). At each end of the stent is an anchor-shaped head to provide fixation. Each head consists of two flexible winglets that fold inwards during insertion through the punctum and spread back out after passage through the junction of the common canaliculus and lacrimal sac, thus securing the stent in place. A centrally placed marking on the tube acts as a reference point and allows verification of proper stent positioning following insertion. The winglets fold backwards for easy removal of the stent from the ducts.

Primary indications for the SRS include horizontal lacrimal duct stricture and punctal stenosis. Special consideration should be given to cancer patients on constricting drug therapies such as Taxotere.

Info FCI Ophthalmics Inc.Call FCI Ophthalmics Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-502-7279

Customer Service: 1-800-932-4202
Web site: http://www.fci-ophthalmics.com

Related medicine products :

1. TLC Self-Retaining Retractor System
2. Assistant Free™ Self-Retaining Hip Surgery Retractor System
3. Bika-Bicanaliculus Intubation
4. Crawford Bicanaliculus Intubation
5. Ritleng Bicanaliculus Intubation
6. Lacrimal Intubation Set, 23 gauge, 3/box
7. Lacrimal Intubation Set, 27 gauge, 3/box
8. Lacrimal Intubation Set, Olive Tip, 27 gauge, 3/box
9. BD Visitec Lacrimal Intubation and DCR Sets
10. Lacrimal Intubation Set
11. Lacrimal Intubation Tubing
... Immunosuppressant Control is a bilevel Cyclosporine control ... unique product is ideal for use with ... levels, such as C2 monitoring, which measures ... hours post-dose., ,Lyphochek Elevated Immunosuppressant Control can ...
Liquichek Hematology-16T Control is a hematology reference control used in monitoring determinations of blood cell values on TOA SYSMEX cell counters....
NEW Liquichek Reticulocyte Control (A)is an assayed whole blood control for evaluating the precision of automated methods of reticulocyte counting....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... Fla. "I used this old family recipe, which is meant to relieve gout and ... it gave me a 12-hour energy boost every time. It relieved what VA doctors ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology: